Strides Pharma Science submits press release

27 Aug 2019

Strides Pharma Science has informed about submission of press release issued by the Company titled: ‘Strides acquires USFDA approved manufacturing facility in the US’.

The above information is a part of company’s filings submitted to BSE.

Related Strides Pharma Science Ltd. Links:

Strides Pharma Scien Share Price

780.65 1.25 (0.16%) Dec 03, 09:43
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 546.55
Dr. Reddys Lab 4858.20
Lupin 917.15
Piramal Enterprises 1442.50
Cadila Healthcare 454.00
View more..
Sensex vs Strides Pharma Scien
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323